Study identifier:D0695L00002
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A randomised, double-blind, multi-centre, parallel group study comparing efficacy and safety of 5 mg/ml ropivacaine and 5 mg/ml bupivacaine for spinal anaesthesia in patients undergoing unilateral lower limb surgery
Anesthesia,Spinal
Phase 3
No
Ropivacaine, Bupivacaine
All
220
Interventional
18 Years - 70 Years
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|